![]() PhaseBio Pharmaceuticals PhaseBio Pharmaceuticals is a biopharmaceutical company committed to developing new and improved drugs, with an initial focus on endocrine and metabolic disorders and cardiovascular disease. | NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies | ||
Founding Date | Founding Date 2002 | Founding Date 2006 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Malvern, US HQ | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations South San Francisco, US HQ |
Employees | Employees 22 | Employees 91 | Employees 11914% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $10.8m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($131.1m) (FY, 2021) | Net income £7m (FY, 2025) | Net income ($176.6m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 157m |
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View company
Tricida operates in the healthcare industry focusing on pharmaceutical business.
View company